Pharmacotherapy with psychotropic drugs

From 6 to 12% of the population of economically developed countries suffer from various mental disorders, more than 80% of which are borderline forms of neuropsychic pathology [2]. These include those psychopathological conditions that are manifested by symptoms of anxiety and fear, increased fatigue and exhaustion, increased irritability, anxious suspiciousness, low mood, obsessions, senestopathies, hypochondria, insomnia, autonomic disorders. These mental disorders are observed both in mental illnesses - neuroses, psychopathies, sluggish schizophrenia, and in neurosis-like and psychopathic conditions arising from somatic diseases [12]. The pathogenesis of borderline states has not been fully studied, but the fundamental idea that psychogenic (sociogenic) and biological (constitutional, genetic, 'exogenous) factors are combined in their origin in a dialectical unity has been established in Russian literature. It is generally accepted that the treatment of patients with borderline conditions should be comprehensive - to combine psycho- and pharmacotherapy [2, 3]. Psychotherapy addresses the psychogenic links of pathogenesis, pharmacotherapy - to biological ones.